AVANOS MEDICAL (NYSE:AVNS) Sets New 1-Year Low - Should You Sell?

AVANOS MEDICAL, INC. (NYSE:AVNS - Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as $11.75 and last traded at $11.93, with a volume of 149903 shares trading hands. The stock had previously closed at $12.14.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of AVANOS MEDICAL from a "hold" rating to a "buy" rating in a research note on Wednesday, March 19th.

AVANOS MEDICAL Trading Down 1.0%

The company has a quick ratio of 1.56, a current ratio of 2.57 and a debt-to-equity ratio of 0.12. The stock's 50 day moving average price is $12.46 and its 200-day moving average price is $14.40. The stock has a market capitalization of $561.58 million, a P/E ratio of -1.45 and a beta of 1.14.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. AVANOS MEDICAL had a negative net margin of 55.80% and a positive return on equity of 6.26%. The company had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. During the same period last year, the firm earned $0.22 earnings per share. AVANOS MEDICAL's revenue was up .8% compared to the same quarter last year. As a group, equities research analysts expect that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current year.

Hedge Funds Weigh In On AVANOS MEDICAL

Several institutional investors and hedge funds have recently bought and sold shares of AVNS. Principal Financial Group Inc. grew its holdings in AVANOS MEDICAL by 3.5% in the fourth quarter. Principal Financial Group Inc. now owns 237,794 shares of the company's stock worth $3,786,000 after purchasing an additional 7,932 shares during the last quarter. Illinois Municipal Retirement Fund grew its holdings in AVANOS MEDICAL by 3.1% in the fourth quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company's stock worth $402,000 after purchasing an additional 748 shares during the last quarter. US Bancorp DE grew its holdings in AVANOS MEDICAL by 18.0% in the fourth quarter. US Bancorp DE now owns 14,093 shares of the company's stock worth $224,000 after purchasing an additional 2,147 shares during the last quarter. Amundi grew its holdings in AVANOS MEDICAL by 200.4% in the fourth quarter. Amundi now owns 23,024 shares of the company's stock worth $355,000 after purchasing an additional 15,359 shares during the last quarter. Finally, Natixis Advisors LLC grew its holdings in AVANOS MEDICAL by 20.9% in the fourth quarter. Natixis Advisors LLC now owns 25,944 shares of the company's stock worth $413,000 after purchasing an additional 4,492 shares during the last quarter. 95.17% of the stock is owned by hedge funds and other institutional investors.

AVANOS MEDICAL Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.